Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | VDR | P11473 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.55 |
| ▸ | PKM | P14618 | 2/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 4/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | HPGD | P15428 | 3/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21749198 | 0.80 | SMN1; SMN2 (0.69) | LMNAKDM4EPKMPOLBNPSR1 | |
| SCHEMBL21749197 | 0.80 | SMN1; SMN2 (0.69) | LMNAKDM4EPKMPOLBNPSR1 | |
| SCHEMBL2084256 | 0.80 | VDR (0.52) | LMNAVDRKDM4EPKMPOLB | |
| SCHEMBL3616241 | 0.80 | KDM4E (0.65) | LMNAVDRKDM4EPKMPOLB | |
| SCHEMBL9674712 | 0.80 | VDR (0.58) | LMNAVDRKDM4EPKMPOLB | |
| SCHEMBL4714535 | 0.78 | VDR (0.53) | VDRKDM4EPKMNPSR1GAA | |
| SCHEMBL2084701 | 0.77 | VDR (0.72) | LMNAVDRKDM4ENPSR1GAA | |
| Hydrochloric Acid SCHEMBL4727347 | 0.77 | VDR (0.56) | LMNAVDRKDM4EPKMPOLB | |
| SCHEMBL9866483 | 0.77 | ALDH1A1 (0.67) | LMNAVDRKDM4EPKMPOLB | |
| SCHEMBL1668107 | 0.77 | KDM4E (0.64) | LMNAKDM4EPKMPOLBNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118374135-B | Antibacterial waterproof high polymer material for tablecloth and preparation method thereof | 东莞市悠悠美居家居制造有限公司 | 2024-12-17 | — | — | CN | claimed |
| CN-118374135-A | Antibacterial waterproof high polymer material for tablecloth and preparation method thereof | 东莞市悠悠美居家居制造有限公司 | 2024-07-23 | — | — | CN | claimed |
| US-12378463-B2 | Water-based resin with elasticity for applications in cementing and subterranean structures | SAUDI ARABIAN OIL COMPANY (SA) | 2025-08-05 | — | — | US | disclosed |
| CN-118374135-B | Antibacterial waterproof high polymer material for tablecloth and preparation method thereof | 东莞市悠悠美居家居制造有限公司 | 2024-12-17 | — | — | CN | disclosed |
| CN-118374135-B | Antibacterial waterproof high polymer material for tablecloth and preparation method thereof | 东莞市悠悠美居家居制造有限公司 | 2024-12-17 | — | — | CN | disclosed |
| CN-118374135-A | Antibacterial waterproof high polymer material for tablecloth and preparation method thereof | 东莞市悠悠美居家居制造有限公司 | 2024-07-23 | — | — | CN | disclosed |
| CN-118374135-A | Antibacterial waterproof high polymer material for tablecloth and preparation method thereof | 东莞市悠悠美居家居制造有限公司 | 2024-07-23 | — | — | CN | disclosed |
| US-20240093081-A1 | WATER-BASED RESIN WITH ELASTICITY FOR APPLICATIONS IN CEMENTING AND SUBTERRANEAN STRUCTURES | SAUDI ARABIAN OIL COMPANY (SA) | 2024-03-21 | — | — | US | disclosed |
| US-11795367-B2 | Water-based resin with elasticity for applications in cementing and subterranean structures | SAUDI ARABIAN OIL COMPANY (SA) | 2023-10-24 | — | — | US | disclosed |
| US-11708522-B1 | Water-based hydrogel polymer composition and methods of treating subterranean formations or cement constructions comprising contaminants | SAUDI ARABIAN OIL COMPANY (SA) | 2023-07-25 | — | — | US | disclosed |
| US-20220409589-A1 | CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY | GENZYME CORP (US) | 2022-12-29 | — | — | US | disclosed |
| US-20040209921-A1 | CXCR4 chemokine receptor binding comounds | ANORMED CORPORATION (CA) | 2004-10-21 | — | — | US | disclosed |
| EP-1465889-A1 | CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY | AnorMED Inc. (CA) | 2004-10-13 | — | — | EP | disclosed |
| US-20040019058-A1 | Chemokine receptor binding heterocyclic compounds with enhanced efficacy | ANORMED CORPORATION (CA) | 2004-01-29 | — | — | US | disclosed |
| US-20030220341-A1 | Chemokine receptor binding heterocyclic compounds with enhanced efficacy | ANORMED, INC. (CA) | 2003-11-27 | — | — | US | disclosed |
| WO-2003055876-A1 | CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY | ANORMED INC. (CA) | 2003-07-10 | — | — | WO | disclosed |
| CN-1378541-A | Inhibitors of c-JUN N-terminal kinase (JNK) and other protein kinases | VERTEX PHARMA (US) | 2002-11-06 | — | — | CN | disclosed |
| EP-0276942-B1 | 6-BETA(SUBSTITUTED)-(S)-HYDROXYMETHYLPENICILLANIC ACIDS AND DERIVATIVES THEREOF | PFIZER INC. (US) | 1992-04-01 | — | — | EP | disclosed |
| US-4782050-A | BACTERICIDES | PFIZER INC. (US) | 1988-11-01 | — | — | US | disclosed |
| EP-0276942-A1 | 6-Beta(substituted)-(S)-hydroxymethylpenicillanic acids and derivatives thereof | PFIZER INC. (US) | 1988-08-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030220341-A1 | Chemokine receptor binding heterocyclic compounds with enhanced efficacy | CCR5, CXCR4, CXCR3 | LMNA 4459/4885VDR 220/4885KDM4E 2947/4885 |
| US-20220409589-A1 | CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY | CCR5, CXCR4, CXCR3 | LMNA 4459/4885VDR 220/4885KDM4E 2947/4885 |
| US-20040019058-A1 | Chemokine receptor binding heterocyclic compounds with enhanced efficacy | CCR5, CXCR4, CXCR3 | LMNA 4459/4885VDR 220/4885KDM4E 2947/4885 |
| US-20040209921-A1 | CXCR4 chemokine receptor binding comounds | CXCR4, CXCR1, CXCR3 | LMNA 4525/4885VDR 382/4885KDM4E 3901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.